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SMALLPOX VACCINATIONS IN THE MANAGEMENT OF RECURRENT
HERPES SIMPLEX: A CONTROLLED EVALUATION*
ARTHUR B. KERN, M.D.t AND BENCEL L. SCHIFF, M.D.f
The management of herpes simplex usually
offers no problem except in those instances in
which the patient is afflicted with recurrent at-
tacks. We have observed cases with lesions occur-
ring as frequently as every two weeks, although
often the intervals are greater. In any event, the
temporary disfigurement produced can be a
source of considerable distress. It is this which
leads the patient to seek aid, aid in the prevention
of further attacks.
What can the physician offer? One form of
treatment dates back to the work of Gilde-
meister and Herzberg (1) who, in 1925, produced
a relative immunity of the rabbit cornea to
smallpox vaccine by previous inoculation with
the virus of herpes simplex. On the basis of these
results they suggested that the herpes virus
might be a variant of that of smallpox. The
following year Heymann (2) cited the obser-
vations of Jenner on the inhibition of the small-
pox vaccine pustule in patients with herpes. In
1928, Freund (3) reported favorable results with
cowpox lymph in the maDagement of seven
patients with recurrent herpes simplex. However,
Bedson and Bland (4), in the same year, on the
basis of their studies on guinea pigs concluded
that the virus of herpes simplex and of vaccinia
are unrelated. Despite the experimental results of
Bedson and Bland, clinical investigations by
Minami and Ohmichi (5) and Wise and Sulz-
berger (6) supported the concept that smallpox
vaccinations helped to prevent attacks of herpes
simplex.
Foster and Abshier (7), in 1937, reported on
35 patients with regular and frequent attacks of
herpes simplex. Vaccinations were given at two
week intervals, most patients receiving a total of
four. In only five patients (14 per cent) did
recurrence follow this therapy. Ullman (8), in
1939, described beneficial effects in four cases
from a single smallpox vaccination. Davis (9), in
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1940, reported good results in his series of 14
cases treated with multiple vaccinations.
In 1941, Woodburne (10) described his results
in 22 cases of herpetic stomatitis treated with two
to fifteen vaccinations. Recurrence occurred in
eight and in each instance cure was induced by
one to seven additional vaccinations. Keddie and
coworkers (11), on the other hand, observed no
decrease in the incidence of herpes simplex in a
series of patients given a single vaccination a few
days to a few weeks prior to artificial fever
therapy. In discussion of this paper, Kile (12)
stated that smallpox vaccinations were of no
value in the management of recurrent herpes
simplex while Schoch (13) and Seale (14) each
stated that they had obtained satisfactory results
with this therapeutic approach.
Arnold (15), in 1944, reported on 14 cases of
recurrent herpetic stomatitis with favorable
response to intradermal injections of smallpox
vaccine. Anderson (16), in 1945, focused attention
on a probable etiologie relationship between
herpes simplex and erythema multiforme. During
the preceding 10 years he had found multiple
vaccinations of value in about 80 per cent of his
cases of recurrent herpes simplex. Accordingly, he
used this same procedure for the prevention of
erythema multiforme associated with herpes
simplex and also in prevention of recurrent
erythema multiforme not associated with herpes.
He found this therapy definitely of value, par-
ticularly in those eases which were preceded by
herpes simplex.
Pepys (17), in 1946, reported on two patients
with recurrent herpes simplex, one with attacks
every two months for 45 years and the other with
attacks every two to three months over a period
of 20 years; no further outbreaks occurred after
three vaccinations.
In 1947 we began treating all our eases of
recurrent herpes simplex with smallpox vacci-
nations. In 1954 we reported our results in a total
of 68 patients (18). This was by no means a very
large series, but, nevertheless, it was the largest
thus far reported. Smallpox vaccinations were
administered by the multiple puncture technic at
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two week intervals. The number varied from two
to eight, most patients receiving two or three.
The duration of disease prior to therapy varied
from one month to 20 years, most patients having
had recurrent attacks for four to five months
before the start of treatment. The number of
attacks before treatment varied from two to
approximately fifty. Frequency of attacks prior
to therapy varied from every 2 to every 32
weeks, 41 patients having had their attacks at
two to three months intervals. Of the 68 patients
in the series, in only 9 did recurrence occur
following the course of treatment and in seven
others there was some question as to possible
recurrence. In summary, 52 patients (76.5 per
cent) definitely had no subsequent attacks during
a lengthy follow-up period.
In attempting to explain these results we con-
sidered three possibilities. The first was that the
living virus in cowpox lymph stimulated the
formation of antibody to herpes simplex virus,
this increased titer preventing recurrence. The
validity of this concept has, however, been
questioned by Burnet (19) who maintained that
the high level of neutralizing antibody reached
within a few weeks after primary infection
remains fairly constant for life. Furthermore, with
an already high titer stimulation of antibody
formation would appear to be of little value.
However, Jawetz, Allende and Coleman (20) have
demonstrated that a given individual may show
considerable fluctuation of antibody level.
Wenner (21) observed complete disappearance of
antibody from the blood of a child seven months
after an attack of Kaposi's varicelliform erup-
tion. Buddingh and co-workers (22) studied the
nentralizing antibody level in 12 children with
primary herpetic gingivostomatitis. Antibodies
were first detected from the fourth to seventh
day following onset of illness, with a rapid in-
crease thereafter. In the majority of cases the
maximum level was reached three to four weeks
after onset. However, this maximum was not
maintained indefinitely, the titer subsequently
dropping to lower levels. In one of their cases
they noted a significant increase in neutralizing
antibody on two occasions; in each instance the
increase occurred during an episode when virus
was recovered from the patient although no
evidence of infection was discernible. Geller,
Coleman and Jawetz (23) injected viable herpes
simplex virus intravenously into 9 subjects. In 4
of these, this was followed by a significant rise in
antibody level.
These reports suggest that at least in some
individuals there is fluctuation in amount of
antibody and that Burnet's concept of a high
fixed level of antibody may be questioned. Can
one postulate, therefore, that it is a fall in anti-
body titer that allows reactivation of virus in
recurrent attacks of herpes simplex? Such a
hypothesis is appealing. However, Scott and
co-workers (24) did neutralizing antibody deter-
minations in three adults with recurrent herpes
simplex and found that regardless of attacks the
level of antibodies remained approximately con-
stant in a given individual. Blank and Rake (25)
have expressed doubt that attempts to increase
the titer of serologic antibodies will be of value in
preventing recurrences. They refer to patients
with frequent attacks whose sera when diluted
500 times would still rapidly inactivate herpes
virus; nevertheless, a million or more virulent
virus particles per milliliter of fluid could be ob-
served within their lesions.
On the basis of the experimental evidence now
available, the role of neutralizing antibody in
recurrent herpes simplex is not clearly estab-
lished. In any event, it appears unlikely that any
benefit obtained from the use of vaccination can
be attributed to stimulation of antibody for-
mation.
The second possible explanation we considered
at the time of our original report was that vacci-
nations might be beneficial as the result of
"suggestion". Such a concept had been proposed
by Ullman (8) and by Blank and Brady (26). We
were however inclined at the time to discount
the role of "suggestion" and to favor the opinion
expressed by Wise and Sulzberger (27) to the
effect that vaccination might act by changing
tissue response in some unknown way.
INvESTIGATIVE STUDY
During the past three years we have attempted,
by means of a controlled series, to evaluate the
possible role of "suggestion". We divided our
patients with recurrent herpes simplex into two
groups. One was given a course of vaccinations
with active smallpox vaccine. The second re-
ceived heat-inactivated vaccine.* The former was
labeled X-0456, the latter X-0457. The person
* Both active and inactive vaccine were sup-
plied through the courtesy of Parke, Davis &
Company, Detroit, Michigan.
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administering the medication was not aware of
which of the two was the active and which the
inactive vaccine. A total of 57 patients are in-
cluded in the series, 34 treated with active
vaccine and 23 with inactive vaccine.
Vaccinations were administered by the multiple
puncture technic and were usually given every
two weeks. The total number received by each
subject in the active group ranged from four to
twelve, with an average of 7.5. The number given
to the inactive group, with one exception, ranged
from five to ten, with an average of 8. One of the
inactive group received only one vaccination;
this patient will be discussed in greater detail
later. All patients were white, with 23 males and
14 females in the active group as compared to 11
males and 12 females in the inactive group. The
age span in the active group was 8 to 60 years,
the average being 27.8, while in the inactive
group it was 7 to 60 years, with an average of 28
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of disease before therapy and the number and
frequency of attacks were approximately the
same for the two groups. Except for a greater
proportion of males in the active group, the two
series of patients were approximately the same.
RESULTS
Of the 34 patients in the active group no re-
currence was observed in 23, or 67 per cent, over
a follow-up period of 6 to 28, months, with an
average follow-up of 20 months. Of the 23
patients in the inactive group no recurrence oc-
curred in 12, or 52 per cent, over a follow-up
period of 6 to 25 months, with an average of 20
months. It should be mentioned that in both
groups there were patients who although showing
recurrence reported that their subsequent attacks
were less frequent and less severe than those prior
to vaccination. One patient in the inactive group
was a 29 year old female who had had monthly
pre-menstrual attacks for four years. Following a
single vaccination she was free of lesions for five
months before her next outbreak of herpes.
DISCUSSION
We regret that the number of patients in our
series is small and that the validity of our results
may therefore be questioned. Nevertheless, the
fact that 52 per cent of those treated with in-
active vaccine were "cured" as compared to the
only slightly better figure of 67 per cent obtained
with active vaccine suggests that the psycho-
therapeutic factor may be the important one. It
might be pointed out that these figures are differ-
ent from those which we reported in July 1958
in our discussion (28) of the paper presented by
G. Douglas Baidridge in the Dermatology Section
of the meeting of the American Medical Associa-
tion. At that time we concluded that although
"suggestion" was a definite factor in some cases,
in most instances vaccination probably achieved
its beneficial effect by inducing some alteration
within the body tissues so as to make them more
resistant to the virus of herpes simplex. However,
statistical analysis and a longer follow-up period
has led to the change in our results.
There are two points that we would like to
bring up at this time. The first concerns the
occurrence of spontaneous cure. It certainly
cannot be denied that in some of our cases
spontaneous cure may have taken place. How-
ever, the long duration and high frequency of
attacks prior to therapy would not make this too
likely. It is, of course, to be assumed that spon-
taneous cure would occur as frequently in one
group as in the other. Secondly, we would like to
make clear the fact that the negligible difference
in results observed in the two series does not
indicate that "suggestion" is necessarily the re-
sponsible factor. It only proves that inoculation
of vaccine containing living cowpox virus is not
appreciably better than inoculation of vaccine
containing heat-inactivated virus. We can only
conclude, therefore, that smallpox vaccinations
are beneficial due 1. to inoculation of a foreign
protein or some other substance within the
vaccine, 2. to "suggestion" or 3. both.
We must confess that when we started this
investigation we were somewhat biased and
expected that our results with the active vaccine
would be superior to those obtained with the
inactive one. Accordingly, we failed to include a
second control, namely inoculation of normal
saline. Had this been done our study would have
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been more conclusive. We have recently started a
new series of patients with recurrent herpes
simplex on inoculations of normal saline in an
attempt to throw further light on this somewhat
beclouded subject.
SUMMARY
Patients with recurrent herpes simplex were
divided into two groups. The first was treated
with multiple smallpox vaccinations. The second
was treated in similar fashion except that the
vaccine used had been inactivated by heat. Fifty-
two per cent of those given inactive vaccine re-
mained free of attacks during the follow-up
period. Sixty-seven per cent of those given the
active vaccine remained free of attacks.
Since the difference in results is negligible one
must conclude that benefit obtained from vacci-
nation is probably due to inoculation of foreign
protein or other substance within the vaccine, to
"suggestion" or possibly to both. It is hoped
that future studies will help us to arrive at a
more specific conclusion.
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